Potential Epigenetic Biomarker for Preeclampsia Identified
Researchers have identified a potential epigenetic biomarker for preeclampsia, offering hope for earlier diagnosis and intervention.
Read MorePosted by Andy Lundin | Dec 5, 2024 | Molecular Diagnostics |
Researchers have identified a potential epigenetic biomarker for preeclampsia, offering hope for earlier diagnosis and intervention.
Read MorePosted by Andy Lundin | Dec 5, 2024 | Molecular Diagnostics |
GeneDx named the partners of its Patient Access Program that provides whole exome sequencing for pediatric epilepsy.
Read MorePosted by Andy Lundin | Dec 2, 2024 | Company News |
QIAGEN is relocating its QIAstat-Dx operations to a new facility in Barcelona to strengthen its syndromic testing capabilities.
Read MorePosted by Andy Lundin | Dec 2, 2024 | Molecular Diagnostics, Unknown Origin & Other Cancer Types |
Mission Bio’s collaboration will leverage single-cell DNA analysis for insights into multiple myeloma relapse and treatment strategies.
Read MorePosted by Chris Wolski | Nov 27, 2024 | Covid 19 |
Investigators have developed an AI tool to analyze electronic health records, helping clinicians identify cases of long COVID.
Read More